Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-12-04
2007-12-04
Coleman, Brenda L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S281000
Reexamination Certificate
active
11252194
ABSTRACT:
A novel hydrate form of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide (“Compound No. 1”) and processes related to the use thereof in the synthesis of a polymorphic form of Compound No. 1.
REFERENCES:
patent: 6384221 (2002-05-01), Thiele et al.
patent: 6399621 (2002-06-01), Dusza et al.
patent: 6472528 (2002-10-01), Gross et al.
patent: 6485746 (2002-11-01), Campbell et al.
patent: 6544999 (2003-04-01), Thiele et al.
patent: 6903106 (2005-06-01), Zook et al.
patent: 2005/0267176 (2005-12-01), Barberich
patent: 2004/018476 (2004-03-01), None
Hettinger Donald
Zook Scott E
Coleman Brenda L.
Moore Susanna
Neurocrine Biosciences Inc.
Seed IP Law Group PLLC
LandOfFree
Hydrate of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrate of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrate of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3891194